Peggrafeel 6mg Injection

About Peggrafeel 6mg Injection

Peggrafeel 6mg Injection is used to prevent infections after chemotherapy. It is a growth factor that stimulates bone marrow to produce white blood cells. These cells protect the body against infections.Peggrafeel 6mg Injection is given as an injection by a qualified medical professional. You should continue to take as long as your doctor advises for it. The duration of treatment varies according to your need and response to treatment. You might be asked for regular tests done to check the number of blood cells in your blood and your bone density level while you are taking this medicine.The most common side effects of this medicine include bone pain, joint pain, headache, nausea, and muscle pain. Other than this, pain or redness at the site of injection is common. But, inform your doctor if you notice a lump, swelling, or bruising that does not go away. It might not prevent you from all kinds of infection, hence inform your doctor if you notice fever, chills, shortness of breath, sore throat, and swelling around the face or neck.Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy. You must avoid driving or attention-seeking activity if you experience dizziness after taking this medicine

How Peggrafeel 6mg Injection Works

Peggrafeel 6mg Injection utilizes its active ingredient, Pegfilgrastim, to stimulate the bone marrow to increase production of neutrophils. These white blood cells are crucial for fighting infection, especially when chemotherapy reduces their normal count. By maintaining higher neutrophil levels, Peggrafeel helps minimize the risk of serious infections during cancer treatment.


Proper Administration and Dosage Guidelines

Peggrafeel 6mg Injection must be administered via subcutaneous injection by a qualified healthcare professional. The exact dosage and frequency are determined by the oncologist or physician based on the patients chemotherapy regimen. Self-administration is not recommended, and proper refrigeration between 2C8C is essential to maintain efficacy.


Benefits and Indications

This injection is specifically recommended for adult cancer patients undergoing chemotherapy to prevent or reduce neutropenia. By lowering infection risk, Peggrafeel enables patients to continue their cancer treatment with fewer interruptions and complications, leading to improved treatment outcomes and quality of life.